Browse the corpus

Influenza viruses belong to the Orthomyxoviridae RNA virus family and are classified into 3 distinct types based on their major antigenic differences: influenza A, influenza B, and influenza C. Influenza viruses cause annual human epidemics, seasonal and pandemics. Seasonal influenza epidemics caused by influenza A and B viruses result in 3 to 5 million severe cases and thousands of deaths globally each year. The influenza A virus causes epidemics and pandemics because of its spread from migrating birds, pigs, horses, and humans. Transmission can be human to human from fomites, coughing, and sneezing. Influenza B exclusively spreads among humans, underscoring its unique transmission pattern limited to human-to-human contact. This singular mode of transmission excludes involvement with other hosts, distinguishing Influenza B from viruses capable of causing pandemics. Influenza C is a mild disease. This activity describes the mode of action of the influenza vaccine, including modes of administration, formulations, adverse event profiles, eligible patient populations, and monitoring, and it highlights the role of the interprofessional team in the management of influenza patients. Participants will gain comprehensive insights into the influenza viruses, their classifications (A, B, and C), and the associated human epidemics, seasonal outbreaks, and pandemics. A thorough understanding of influenza viruses, vaccination strategies, and tailored recommendations for diverse patient populations is emphasized. Clinicians will acquire an understanding of the indications for vaccination, incorporating recommendations from the Advisory Committee on Immunization Practices and the Centers for Disease Control and Prevention, targeting specific age groups and individuals with underlying health conditions. Objectives: Differentiate between the various influenza virus types (A, B, and C) to tailor vaccination strategies based on their distinct characteristics and transmission patterns. Assess the absolute and relative contraindications of the influenza vaccine. Implement evidence-based vaccination protocols, incorporating the latest recommendations from authoritative bodies such as the Advisory Committee on Immunization Practices and the Centers for Disease Control and Prevention, ensuring accurate and timely administration.

Assess the absolute and relative contraindications of the influenza vaccine. Implement evidence-based vaccination protocols, incorporating the latest recommendations from authoritative bodies such as the Advisory Committee on Immunization Practices and the Centers for Disease Control and Prevention, ensuring accurate and timely administration. Collaborate with an interprofessional team to develop and implement comprehensive influenza vaccination strategies, promoting a unified approach to preventive healthcare. Access free multiple choice questions on this topic.

The vaccine does not manifest any dose-dependent toxicity. Despite extensive studies, no toxicity regarding carcinogenicity and infertility has been found. The components of the influenza vaccine are the following: Formaldehyde which is used to inactivate toxins from viruses and bacteria. Thimerosal which safeguards against contamination and is only present in multi-dose vials. Aluminum salts which act as adjuvants and impart a more robust immune response. Gelatin which is present as a stabilizer. Antibiotics, such as gentamicin or neomycin, which are present in the flu vaccine to keep bacteria from growing. Toxicity does not exist due to the inconspicuous amounts of these components in the vaccine.[17][18]

Vaccination is the primary strategy for the prevention and control of influenza. Vaccination success depends upon its promotion by health professionals, including physicians, advanced care practitioners,  nurses, pharmacists, and others working as an interprofessional team. A proper understanding of the vaccine's benefits is mandatory. Discouraging vaccination for trivial reasons should be avoided. Healthcare professionals should be encouraged to be vaccinated themselves. Physicians, advanced practitioners, nurses, and pharmacists need refined skills in assessing patient eligibility, administering vaccines, and addressing potential adverse events. Proficient injection techniques and communication skills enhance patient experience and adherence to vaccination recommendations. Developing comprehensive vaccination strategies is crucial. This includes targeted outreach to high-risk populations, effective communication campaigns, and integrating influenza vaccination into routine healthcare practices. Strategies should be adaptable to evolving recommendations and public health priorities. Vaccinating pregnant women is advised. Influenza infection during pregnancy after vaccination tends to be less severe, and complications are reduced. It helps to protect the infant against flu during the crucial first 6 months of life as the mother passes the immune protection to her newborn.[19][3] Individual vaccination of pregnant women should be complemented by cocoon protection, achieved through the vaccination of those in close proximity. This approach provides a protective barrier, reducing the risk of influenza transmission to pregnant individuals and safeguarding maternal and fetal health. With all 50 states in the US permitting pharmacists to administer influenza vaccines, patient access to the vaccine has never been more available. Pharmacists must coordinate their efforts with other interprofessional healthcare team members to ensure patients are appropriate candidates for the vaccine and that the patient's vaccine record is updated so that all team members benefit from the same patient data. Interprofessional collaboration ensures shared understanding, coordinated efforts, and efficient information exchange, ultimately benefiting patient care and safety.

With all 50 states in the US permitting pharmacists to administer influenza vaccines, patient access to the vaccine has never been more available. Pharmacists must coordinate their efforts with other interprofessional healthcare team members to ensure patients are appropriate candidates for the vaccine and that the patient's vaccine record is updated so that all team members benefit from the same patient data. Interprofessional collaboration ensures shared understanding, coordinated efforts, and efficient information exchange, ultimately benefiting patient care and safety. The real scientific challenge in the primary strategy for preventing and controlling the influenza virus is antigenic drifts and shifts. Annual vaccination is the current recommendation due to waning immunity. A universal influenza vaccine is undergoing trials and serves the purpose of building a single vaccine that targets all virus strains, which will, in turn, minimize the need for frequent vaccination.[20][21] Pursuing a universal flu vaccine promises to provide lasting and comprehensive protection against diverse influenza strains, potentially revolutionizing global influenza prevention efforts.